Organisation paid for research Program year 2025 Source: CMS Open Payments

Health Research Inc.

Neither a doctor nor a teaching hospital

Research payments

$189,696

52 payments

Through program year 2025, Health Research Inc. is reported as receiving $189,696 in research payments, across 52 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$35,416	2
2024	Research	$1,970	42
2022	Research	$96,776	1
2021	Research	$9,618	3
2020	Research	$19,742	2
2019	Research	$26,174	2

Breakdown

Who paid Research payments · program years 2019–2025

AbbVie, Inc. $96,776 1 payment
Merck Sharp & Dohme Corporation $35,416 2 payments
Daiichi Sankyo Inc. $28,144 44 payments
Progenics Pharmaceuticals, Inc. $22,421 4 payments
Myriad Genetic Laboratories, Inc. $6,939 1 payment

Studies the money was for Research payments · program years 2019–2025

Phase I/II study of ENZALUTAMIDE with VENETOCLAX (ABT-199) in patients with metastatic castrate resistant prostate cancer (mCRPC) $96,776 1 payment
Phase 2 Study of MK-6482 in Participants With Advanced Renal Cell Carcinoma $28,990 1 payment
Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone (ARROW) $19,742 2 payments
Ac220007 $16,040 1 payment
Ds3032-A-U102 $10,135 1 payment
EndoPredict Extended Endocrine Trial (EXET) $6,939 1 payment
Phase 2 Study of MK-6482 in Participants With Advanced Renal Cell Carcinoma $6,425 1 payment
Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant $2,679 2 payments
U31402-277 $1,970 42 payments

What the money was spent on Research payments · program years 2019–2025

Patient care $2,679 2 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.